ICD-11 classes
X Extension Codes
Histopathology
Adenomas and adenocarcinomas
Adenocarcinomas, malignant

ICD-11 Adenocarcinomas, malignant

The diagnosis has no description.

The diagnosis includes nothing.

The diagnosis excludes nothing.

Diagnosis contains 157 clarifying diagnoses:

  1. XH2QZ6 Acidophil carcinoma
  2. XH5LA4 Adenocarcinoid tumour
  3. XH74S1 Adenocarcinoma, NOS
  4. XH7QZ0 Adenocarcinoma in adenomatous polyp
  5. XH2ZH8 Adenocarcinoma in adenomatous polyposis coli
  6. XH9YR3 Adenocarcinoma in multiple adenomatous polyps
  7. XH7QB1 Adenocarcinoma in tubulovillous adenoma
  8. XH6DA5 Adenocarcinoma in villous adenoma
  9. XH5RE1 Adenocarcinoma of anal glands
  10. XH2ZQ0 Adenocarcinoma with mixed subtypes
  11. XH0349 Adenocarcinoma, intestinal type
  12. XH8B45 Solid carcinoma, NOS
  13. XH8DS0 Neuroendocrine tumour, NOS
  14. XH8LX8 Neuroendocrine carcinoma, low grade
  15. XH55D7 Neuroendocrine carcinoma, well-differentiated
  16. XH9LV8 Neuroendocrine tumor, grade 1
  17. XH7NM1 Enterochromaffin cell carcinoid
  18. XH0U20 Neuroendocrine carcinoma, NOS
  19. XH7F73 Neuroendocrine carcinoma, moderately differentiated
  20. XH24W2 Lepidic adenocarcinoma
  21. XH3QM0 Minimally invasive adenocarcinoma, Non-mucinous
  22. XH4302 Adenoid cystic carcinoma
  23. XH2098 Minimally invasive adenocarcinoma, Mucinous
  24. XH6LV9 Papillary adenocarcinoma, NOS
  25. XH95U1 Villoglandular carcinoma
  26. XH6QG3 Micropapillary carcinoma, NOS
  27. XH4MW7 Micropapillary adenocarcinoma
  28. XH7KL6 Pituitary carcinoma, NOS
  29. XH6L02 Clear cell adenocarcinoma, NOS
  30. XH5085 Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma
  31. XH1442 MiT Family translocation carcinomas
  32. XH8EN1 Succinate dehydrogenase deficient renal cell carcinoma
  33. XH07X3 Alveolar adenocarcinoma
  34. XH05V6 Renal cell carcinoma, NOS
  35. XH3Z08 Renal cell carcinoma, unclassified
  36. XH0RU3 Acquired cystic disease associated renal cell carcinoma
  37. XH7K79 Tubulocystic renal cell carcinoma
  38. XH1VB1 Hybrid oncocytic chromophobe tumour
  39. XH3Z50 Follicular carcinoma, NOS
  40. XH9508 Endometrioid adenocarcinoma, ciliated cell variant
  41. XH0718 Endometrioid adenocarcinoma, secretory variant
  42. XH4KH2 Adrenal cortical carcinoma
  43. XH0SD2 Endometrioid adenocarcinoma, NOS
  44. XH51K1 Neuroendocrine tumour, grade 2
  45. XH09B7 Endometrioid cystadenocarcinoma
  46. XH6KR7 Endometrioid adenofibroma, malignant
  47. XH0GS9 Adenocarcinoma, endocervical type
  48. XH8SF8 Islet cell adenomatosis
  49. XH43E4 Perihilar cholangiocarcinoma
  50. XH4BY1 Islet cell adenoma
  51. XH3CU4 Villoglandular variant of endometrioid adenocarcinoma
  52. XH5QV8 Pituitary blastoma
  53. XH0Y80 Follicular carcinoma, encapsulated, angioinvasive
  54. XH46F1 Clear cell renal cell carcinoma, NOS
  55. XH9SA7 Basal cell adenocarcinoma
  56. XH85C2 Endolymphatic sac tumor
  57. XH4PB1 Acinar adenocarcinoma of prostate
  58. XH8E54 Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)
  59. XH5QW8 Neuroendocrine tumour, grade 3
  60. XH1NL5 Nesidioblastoma
  61. XH5XB7 Islet cell carcinoma
  62. XH2ST7 Islet cell tumor, NOS
  63. XH4SH8 Insulinoma, NOS
  64. XH93H8 Gastrinoma
  65. XH7JQ0 Parathyroid carcinoma
  66. XH9LV7 Basophil carcinoma
  67. XH7152 Glucagon-like peptide-producing tumour
  68. XH7LW9 L-cell tumour
  69. XH9ZS8 Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumour
  70. XH4NQ8 Glucagonoma
  71. XH2PF0 Enteroglucagonoma
  72. XH72E5 Vipoma
  73. XH5VH0 Somatostatinoma
  74. XH41P2 Endocrine tumour, functioning, NOS
  75. XH7AG8 ACTH-producing tumour
  76. XH60V1 Medullary thyroid carcinoma
  77. XH3BU6 Bile duct cystadenocarcinoma
  78. XH2MW1 Medullary carcinoma with amyloid stroma
  79. XH8VU6 Poorly differentiated thyroid carcinoma
  80. XH4NH4 Pituitary neuroendocrine tumour
  81. XH2ZA2 Bronchial adenoma, carcinoid
  82. XH5TR7 Adenocarcinoma of lung, mixed mucinous and non-mucinous
  83. XH7GY6 Adenocarcinoma of lung, mucinous
  84. XH2035 Bronchiolo-alveolar carcinoma, non- mucinous
  85. XH6LF9 Carcinoma simplex
  86. XH0XL5 Carcinoma, diffuse type
  87. XH7M15 Cholangiocarcinoma
  88. XH7SS7 Chromophobe carcinoma
  89. XH2Q13 Clear cell adenocarcinofibroma
  90. XH6YS0 Clear cell adenocarcinoma, mesonephroid
  91. XH4SQ4 Collecting duct carcinoma
  92. XH7QJ6 Combined hepatocellular carcinoma and cholangiocarcinoma
  93. XH4KK0 Cyst-associated renal cell carcinoma
  94. XH0LH8 Enterochromaffin-like cell tumour
  95. XH5P16 Fetal adenocarcinoma
  96. XH7TE3 Follicular adenocarcinoma, moderately differentiated
  97. XH0VD1 Follicular adenocarcinoma, trabecular
  98. XH8FK7 Follicular adenocarcinoma, well differentiated
  99. XH3DN7 Follicular carcinoma, minimally invasive
  100. XH90N9 Follicular carcinoma, oxyphilic cell
  101. XH3XT5 Glycogen-rich carcinoma
  102. XH4262 Goblet cell carcinoid
  103. XH2EH4 Granular cell carcinoma
  104. XH4T58 Hepatocellular carcinoma, clear cell type
  105. XH9Q35 Hepatocellular carcinoma, fibrolamellar
  106. XH0G90 Hepatocellular carcinoma, pleomorphic type
  107. XH5761 Hepatocellular carcinoma, scirrhous
  108. XH3T17 Hepatocellular carcinoma, spindle cell variant
  109. XH6YH5 Hurthle cell adenocarcinoma
  110. XH8MQ3 Hurthle cell carcinoma
  111. XH8WM4 Linitis plastica
  112. XH6TK0 Lipid-rich carcinoma
  113. XH81N8 Merkel cell carcinoma
  114. XH7019 Mixed acidophil-basophil carcinoma
  115. XH8EZ3 Mixed acinar-endocrine carcinoma
  116. XH74Y9 Mixed acinar-endocrine-ductal carcinoma
  117. XH6H10 Mixed adenoneuroendocrine carcinoma
  118. XH2AM6 Mixed cell adenocarcinoma
  119. XH7CY5 Mixed ductal-endocrine carcinoma
  120. XH6UP4 Mixed endocrine and exocrine adenocarcinoma
  121. XH7DG7 Mixed medullary-follicular carcinoma
  122. XH3340 Mixed medullary-papillary carcinoma
  123. XH9LZ7 Mixed pancreatic endocrine and exocrine tumour, malignant
  124. XH1108 Nonencapsulated sclerosing carcinoma
  125. XH09D6 Oxyphilic adenocarcinoma
  126. XH3614 Islet cell adenocarcinoma
  127. XH3709 Pancreatic neuroendocrine tumor, nonfunctioning
  128. XH6XY9 Pancreatobiliary-type carcinoma
  129. XH1ND9 Papillary carcinoma of thyroid
  130. XH85E5 Papillary carcinoma, columnar cell
  131. XH0426 Papillary carcinoma, diffuse sclerosing
  132. XH0Q59 Papillary carcinoma, encapsulated, of thyroid
  133. XH29M4 Papillary carcinoma, follicular variant
  134. XH5YT2 Papillary carcinoma, oncocytic variant
  135. XH2AW7 Papillary microcarcinoma
  136. XH1D07 Papillary renal cell carcinoma
  137. XH4Q20 Papillotubular adenocarcinoma
  138. XH1JZ0 Parietal cell carcinoma
  139. XH6153 Renal cell carcinoma, chromophobe type
  140. XH9DH7 Renal cell carcinoma, sarcomatoid
  141. XH4FS4 Scirrhous adenocarcinoma
  142. XH34G3 Solid carcinoma with mucin formation
  143. XH0JE3 Superficial spreading adenocarcinoma
  144. XH7EX3 Trabecular adenocarcinoma
  145. XH4TA4 Tubular adenocarcinoma
  146. XH1Z69 Typical carcinoid
  147. XH22Z8 Carcinoma of Skene, Cowper and Littre Glands
  148. XH0X20 Villous adenocarcinoma
  149. XH0A57 Water-clear cell adenocarcinoma
  150. XH8UE4 Adenocarcinoma, metastatic, NOS
  151. XH4ZC3 Basal cell carcinoma of the prostate
  152. XH4W48 Hepatocellular carcinoma, NOS
  153. XH81Q9 Bronchial adenoma, cylindroid
  154. XH92Y9 Thymic carcinoma with adenoid cystic carcinoma-like features
  155. XH1YZ3 Cribriform carcinoma, NOS
  156. XH4YG1 Cribriform comedo-type carcinoma
  157. XH74B2 Serrated adenocarcinoma

The diagnosis is coded elsewhere:

Search results